Nalesnik MA - Search Results

1

Liver-specific deletion of augmenter of liver regeneration accelerates development of steatohepatitis and hepatocellular carcinoma in mice.

Gandhi CR, Chaillet JR, Nalesnik MA, Kumar S, Dangi A, Demetris AJ, Ferrell R, Wu T, Divanovic S, Stankeiwicz T, Shaffer B, Stolz DB, Harvey SA, Wang J, Starzl TE. Gandhi CR, et al. Among authors: nalesnik ma. Gastroenterology. 2015 Feb;148(2):379-391.e4. doi: 10.1053/j.gastro.2014.10.008. Epub 2014 Oct 13. Gastroenterology. 2015. PMID: 25448926 Free PMC article.

2

Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease.

Randhawa PS, Jaffe R, Demetris AJ, Nalesnik M, Starzl TE, Chen YY, Weiss LM. Randhawa PS, et al. N Engl J Med. 1992 Dec 10;327(24):1710-4. doi: 10.1056/NEJM199212103272403. N Engl J Med. 1992. PMID: 1331789 Free PMC article.

3

The protective effect of FK506 pretreatment against renal ischemia/reperfusion injury in rats.

Sakr M, Zetti G, McClain C, Gavaler J, Nalesnik M, Todo S, Starzl T, Van Thiel D. Sakr M, et al. Transplantation. 1992 May;53(5):987-91. doi: 10.1097/00007890-199205000-00004. Transplantation. 1992. PMID: 1374948 Free PMC article.

4

The effect of FK 506 and CyA on the Lewis rat renal ischemia model.

Nalesnik MA, Lai HS, Murase N, Todo S, Starzl TE. Nalesnik MA, et al. Transplant Proc. 1990 Feb;22(1):87-9. Transplant Proc. 1990. PMID: 1689911 Free PMC article. No abstract available.

5

Effect of FK 506 on spontaneous diabetes in BB rats.

Murase N, Lieberman I, Nalesnik MA, Mintz DH, Todo S, Drash AL, Starzl TE. Murase N, et al. Among authors: nalesnik ma. Diabetes. 1990 Dec;39(12):1584-6. doi: 10.2337/diab.39.12.1584. Diabetes. 1990. PMID: 1700959 Free PMC article.

6

Lymphoproliferative disorders arising under immunosuppression with FK 506: initial observations in a large transplant population.

Nalesnik MA, Demetris AJ, Fung JJ, Starzl TE. Nalesnik MA, et al. Transplant Proc. 1991 Feb;23(1 Pt 2):1108-10. Transplant Proc. 1991. PMID: 1703335 Free PMC article. No abstract available.

7

FK 506 prevents spontaneous diabetes in the BB rat.

Murase N, Lieberman I, Nalesnik M, Mintz D, Todo S, Drash AL, Starzl TE. Murase N, et al. Transplant Proc. 1991 Feb;23(1 Pt 1):551-5. Transplant Proc. 1991. PMID: 1703705 Free PMC article.

8

FK 506 ameliorates the hepatic injury associated with ischemia and reperfusion in rats.

Sakr MF, Zetti GM, Hassanein TI, Farghali H, Nalesnik MA, Gavaler JS, Starzl TE, Van Thiel DH. Sakr MF, et al. Among authors: nalesnik ma. Hepatology. 1991 May;13(5):947-51. Hepatology. 1991. PMID: 1709412 Free PMC article.

9

FK 506 modulates D-galactosamine-induced hepatitis in rats.

Farghali H, Gasbarrini A, Borle AB, Nalesnik MA, Francavilla A, Fagiuoli S, Starzl TE, Van Thiel DH. Farghali H, et al. Among authors: nalesnik ma. Transplant Proc. 1991 Dec;23(6):2809-11. Transplant Proc. 1991. PMID: 1721285 Free PMC article. No abstract available.

10

Lymphocyte traffic and graft-versus-host disease after fully allogeneic small bowel transplantation.

Murase N, Demetris AJ, Woo J, Furuya T, Nalesnik M, Tanabe M, Todo S, Starzl TE. Murase N, et al. Transplant Proc. 1991 Dec;23(6):3246-7. Transplant Proc. 1991. PMID: 1721424 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

268 results

Search Page

Filters